| Accession Number | 0001193125-26-355911 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Aug 15, 2026 | Exercise/Conversion | 102,000 | โ | โ | 216,487 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Aug 17, 2026 | Sale | 20,679 | $0.72 | $14,930.24 | 195,808 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Aug 18, 2026 | Sale | 17,043 | $0.84 | $14,365.54 | 178,765 | Direct | โ | View Details | |
Chief Scientific Officer | Restricted Stock Units | Derivative | Aug 15, 2026 | Exercise/Conversion | 102,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |